ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÕÔÏÖÍ¢£©4ÔÂ13ÈÕ£¬Ö×Áöѧ¹ú¼Ê¶¥¼âÆÚ¿¯Cancer CellÔÚÏß½ÒÏþÁËngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÐìÈ𻪽ÌÊÚÍŶÓÔÚÍíÆÚʳ¹ÜÁÛ°©ÃâÒßÖÎÁÆ·½Ãæ×îеÄǰհÐÔת»¯Ñо¿Ð§¹û¡£ÔÚÕâÏîÑо¿ÖУ¬ÐìÈ𻪽ÌÊÚÍŶӻùÓÚJUPITER-06Ñо¿µÄ»ùÒò²âÐòÊý¾Ý£¬½¨ÉèÁËÒÔ»ùÒò×éÌØÕ÷ΪÒÀ¾ÝµÄEsophageal cancer Genome-based Immuno-oncology Classification (EGIC)·ÖÐÍ£¬ÍØ¿íÁËÍíÆÚʳ¹ÜÁÛ°©(ESCC)Ò»Ïß¡°PD-1¿¹Ìå+»¯ÁÆ¡±Ä£Ê½µÄÉúÎï±ê¼ÇÎï̽Ë÷Æ«Ïò£¬ÎªÍíÆÚʳ¹ÜÁÛ°©ÌṩÁËеÄÃâÒßÖÎÁƾöÒéÊֶΡ£
È«Çòʳ¹Ü°©Äêз¢60.41ÍòÀý£¬ÄêéæÃü54.41ÍòÀý£¬ÊÇΣº£º£º¦ÈËÀ࿵½¡µÄÖØ´ó¼²²¡Ö®Ò»¡£Ê³¹Ü°©Ö÷Òª°üÀ¨Ê³¹ÜÏÙ°©£¨EAC£©ºÍʳ¹ÜÁÛ°©£¨ESCC£©£¬ÆäÖÐʳ¹ÜÁÛ°©×îΪ³£¼û£¬Õ¼È«Çòʳ¹Ü°©µÄ85%¡£ºã¾ÃÒÔÀ´£¬¹ØÓÚÍíÆÚʳ¹ÜÁÛ°©µÄÖÎÁÆÒÔ´¿´â»¯ÁÆ·½°¸ÎªÖ÷£¬µ«»¼ÕßÉúÑÄ»ñÒæÓÐÏÞ£¬Ô¤ºó²»¼Ñ¡£½üÄêÀ´£¬¶àÏî´óÐÍ3ÆÚËæ»ú±ÈÕÕÑо¿£¨KEYNOTE-590¡¢¡¢CheckMate 648¡¢¡¢ESCORT-1st¡¢¡¢JUPITER-06¡¢¡¢ORIENT-15¡¢¡¢RATIONALE-306¡¢¡¢ASTRUM-007£©Ö¤ÊµÁË¡°PD-1¿¹Ìå+»¯ÁÆ¡±Ä£Ê½ÓÃÓÚÍíÆÚʳ¹Ü°©Ò»ÏßÖÎÁƵÄÁÆÐ§¡£ÆäÖУ¬JUPITER-06Ñо¿Êý¾ÝÏÔʾ£¬Ïà±ÈÓÚ´¿´â»¯ÁÆ£¬ÌØÈðÆÕÀûµ¥¿¹£¨PD-1¿¹Ì壩ÁªºÏ»¯ÁÆ£¨×Ïɼ´¼+˳²¬£©Ò»ÏßÖÎÁÆÍíÆÚʳ¹ÜÁÛ°©»¼Õß¿ÉÒÔÏÔÖø¸ÄÉÆÆäÎÞÏ£ÍûÉúÑÄÆÚ£¨PFS£©ºÍ×ÜÉúÑÄÆÚ£¨OS£©£¬½µµÍéæÃü·çÏÕ´ï42%¡£»£»ùÓÚÕâÒ»Í»ÆÆÐÔЧ¹û£¬ÌØÈðÆÕÀûµ¥¿¹ÁªºÏ×Ïɼ´¼¼°Ë³²¬µÄ·½°¸ÒѳÉΪÍíÆÚESCCµÄÒ»Ïß±ê×¼ÖÎÁÆ·½°¸¡£
È»¶ø£¬KEYNOTE-590¡¢¡¢CheckMate-648Ñо¿Ð§¹ûÏÔʾ£¬PD-L1µÍ±í´ï»¼Õß½ÓÊÜPD-1µ¥¿¹ÁªºÏ»¯ÁÆÎ´ÏÔʾ³öÏÔÖøÓÅÓÚ´¿´â»¯ÁƵÄÁÙ´²»ñÒæ¡£Îª´Ë£¬ÐìÈ𻪽ÌÊÚÍŶÓǰÆÚ¶ÔJUPITER-06Ñо¿¿ªÕ¹ÁË»ùÓÚPD-L1±í´ïˮƽµÄÑÇ×éÆÊÎö£¬Ð§¹ûÏÔʾPD-L1¸ß±í´ïºÍµÍ±í´ïµÄ»¼ÕßÔÚ»¯ÁÆ»ù´¡ÉÏÁªºÏPD-1¿¹ÌåÖÎÁƾùÄÜÏÔÖø»ñÒæ¡£±ðµÄ£¬Ñо¿ÍŶӶÔÏàͬÁìÓòµÄÎåÏî3ÆÚÁÙ´²ÊÔÑé¾ÙÐÐÁËÜöÝÍÆÊÎö£¬½øÒ»²½ÑéÖ¤ÁËÕâÒ»½áÂÛ¡£ÕâÒ»Ñо¿Ð§¹ûÅú×¢£º£º£ºÔÚ¡°PD-1¿¹Ìå+»¯ÁÆ¡±µÄÖÎÁÆÄ£Ê½Ï£¬PD-L1±í´ïˮƽ×÷ΪÁÆÐ§±ê¼ÇÎïµÄÓ¦ÓüÛÖµÓÐÏÞ£¬Ø½Ðè×·Çó¸üΪ¿É¿¿µÄÁÆÐ§±ê¼ÇÎï¡£
ÃæÁÙ´ËÄæ¾³£¬ÐìÈ𻪽ÌÊÚÍŶӻùÓÚJUPITER-06ÁÙ´²ÐÐÁпªÕ¹ÁËǰհÐÔÁÙ´²×ª»¯Ñо¿£¬¶ÔÑо¿ÖÐ486Ãûʳ¹ÜÁÛ°©»¼ÕßµÄÖÎÁÆÇ°Ö×Áö×éÖ¯¾ÙÐÐÁËÈ«ÍâÏÔ×Ó²âÐò£¬Ì½Ë÷¡°PD-1¿¹Ìå+»¯ÁÆ¡±Ä£Ê½ÏµÄÁÆÐ§±ê¼ÇÎï¼°¾«×¼ÖÎÁÆÕ½ÂÔ¡£
Ñо¿ÍŶÓÊ×ÏÈ·¢Ã÷£¬Í¨¹ý±íÕ÷ÃâÒßÔÐÔÔ¤²âÃâÒßÖÎÁÆÁÆÐ§µÄÖ×ÁöÍ»±ä¸ººÉ£¨TMB£©ºÍ½ö˼Á¿¿Ë¡ÐÔÍ»±äµÄclonal TMB¾ùÎÞ·¨ÓÐÓÃÔ¤²âÔÚʳ¹ÜÁÛ°©»¯ÁÆÁªºÏPD-1¿¹ÌåµÄÁÆÐ§£¬Õâ¿ÉÄÜÓëÆä±íÕ÷Ö×ÁöÃâÒßÔÐÔµÄ׼ȷ¶Èȱ·¦Óйء£¼ÈÍùÑо¿·¢Ã÷£¬¿½±´Êý±äÒìºÍÍ»±äÊÂÎñ±¬·¢µÄÏȺó¹ØÏµ»áÓ°Ïì±äÒìëĶκÍÒ°ÉúÐÍëĶαí´ïµÄÏà¶ÔƷò£¬´Ó¶øÓ°ÏìÍ»±äµÄÃâÒßÔÐÔ¡£Ñо¿ÍŶÓÊ×ÏÈÆ¾Ö¤¿Ë¡ÐÔÍ»±ä±¬·¢ÇøÓòµÄ¿½±´Êý±äÒ죨CNA£©ÇéÐÎ¶ÔÆä×ö³ö·ÖÀ࣬²¢Æ¾Ö¤ÍƶϵÄCNAºÍÍ»±ä±¬·¢µÄÏȺó¹ØÏµ£¬½øÒ»²½½«±¬·¢ÔÚÀ©ÔöÇøÓòµÄÍ»±äÇø·ÖΪCNA-earlyÍ»±äºÍCNA-lateÍ»±ä£»£»½«CNA-lateÍ»±äɨ³ý²¢¶ÔÊ£ÓàµÄÍ»±äÊýÄ¿¾ÙÐÐÇóºÍ£¬½ç˵Ϊ¿½±´Êý±äÒìУÕýµÄTMB£¨CNA-corrected TMB, ccTMB£©¡£Ð§¹ûÏÔʾ£¬¾ßÓиßccTMBµÄ»¼Õß´Ó»¯ÁÆÁªºÏPD-1¿¹ÌåÖеĻñÒæÏÔÖøÓÅÓÚµÍccTMBµÄ»¼Õߣ¬ÔÚ¹ú¼ÊÉÏÊ×´Î֤ʵÁËÓÅ»¯µÄÃâÒßÔÐÔÖ¸±êÔÚ¡°PD-1¿¹Ìå+»¯ÁÆ¡±Ä£Ê½Ï¿É×÷Ϊ¿É¿¿µÄÁÆÐ§±ê¼ÇÎï¡£

¿½±´Êý±äÒìУÕýTMBµÄ¹¹½¨Á÷³Ì
ÓÉÓÚÈËÀà°×ϸ°û¿¹Ô£¨HLA£©·Ö×Ó¹ØÓÚ¿¹ÔµÄ³ÊµÝЧÂÊͬÑùÓ°ÏìÖ×Áöϸ°ûµÄÃâÒßÔÐÔ£¬Ñо¿ÍŶÓͬʱÆÊÎöÁËHLA»ùÒòÐͺͻ¯ÁÆÁªºÏPD-1¿¹Ìå»ñÒæµÄ¹ØÏµ£¬²¢ÇÒ·¢Ã÷HLA-BºÍHLA-IIµÄ¶àÑùÐÔ¡¢¡¢ÒÔ¼°·ÇHLA-B1501µÄHLA-B62³¬ÐÍÊÇ»¯ÁÆÁªºÏPD-1¿¹ÌåµÄÕýÐÔÁÆÐ§Ô¤²â±ê¼ÇÎÁªºÏccTMB¿ÉÒÔ½øÒ»²½×é³ÉÓÅ»¯µÄÃâÒßÔÐÔÖ¸±ê£¬Ìá¸ßÔ¤²âЧÄÜ¡£²¿·Ö»ùÒò×éÖÂÁö±äÒìÒѱ»Ö¤ÊµÓëPD-1¿¹Ìåµ¥Ò©ÄÍÒ©Ïà¹Ø¡£Ñо¿ÍŶÓͨ¹ý¶ÔÏÔÖøÍ»±ä»ùÒòºÍÏÔÖø±¬·¢¿½±´Êý±äÒìµÄɸѡ£¬·¢Ã÷TET2Í»±ä£¬PIK3CAÍ»±ä£¬È¾É«Ìå1q21.3Çø¶ÎÀ©ÔöºÍȾɫÌå22q11.21Çø¶ÎÀ©ÔöÓëESCC»¼Õß¶Ô»¯ÁÆÁªºÏPD-1¿¹ÌåÄÍÒ©Ïà¹Ø¡£
ÃâÒßÔÐԺͷçÏÕÖÂÁö±äÒìÊÇÖ×Áö»ùÒò×éÓ°ÏìÃâÒßÖÎÁÆ»ñÒæµÄÁ½·½ÃæÒòËØ¡£Îª´Ë£¬Ñо¿ÍŶӽøÒ»²½½«ÉÏÊöÅжϵÄÃâÒßÔÐÔÖ¸±êºÍ·çÏÕÖÂÁö±äÒì¾ÙÐÐÁËÕûºÏ£¬¹¹½¨ÁËEGIC·ÖÐÍ£¬½«ÃâÒßÔÐÔÓÐÀûÓÚÁªºÏÖÎÁÆÇÒ·çÏÕÖÂÁö±äÒìÒõÐԵϼÕß½ç˵ΪEGIC1ÐÍ£¬75%ÒÔÉϵĸÃÐÍ»¼ÕßÔÚ»¯ÁÆÁªºÏPD-1¿¹ÌåÖÎÁÆÖлñµÃ³ÖÐøÐÔ»ñÒæ£¬ÇÒÉúÑÄÇúÏßµÄÍÏβЧӦÏÔ×Å£»£»½«ÃâÒßÔÐÔÓÐÀûÓÚÁªºÏÖÎÁÆ»ò·çÏÕÖÂÁö±äÒìÒõÐԵϼÕß½ç˵ΪEGIC2ÐÍ£¬¸ÃÐÍ»¼ÕßÔÚ¸ÃÁªºÏģʽÖÐÒ²ÓÐÒ»¶¨µÄ»ñÒæ£»£»½«ÃâÒßÔÐÔµ¹ÔËÓÚÁªºÏÖÎÁÆ»ò·çÏÕÖÂÁö±äÒìÑôÐԵϼÕß½ç˵ΪEGIC3ÐÍ£¬¸ÃÐÍ»¼ÕßÎÞ·¨ÔÚ»¯ÁÆÁªºÏPD-1¿¹ÌåÖÐÈ¡µÃ»ñÒæ¡£¹ØÓÚEGIC3ÐÍ»¼Õߣ¬Í¨¹ýÁªºÏ°ÐÏò¸ÉÔ¤ËùЯ´øµÄ·çÏÕÖÂÁö±äÒì·Ö×ÓÊÂÎñ¿ÉÄÜÊǽøÒ»²½Ìá¸ßESCC»¼ÕßÖÎÁÆ»ñÒæµÄ¿ÉÐÐÕ½ÂÔ¡£

EGIC·ÖÐ͵Ĺ¹½¨£¨ÉÏ£©ÒÔ¼°²î±ðEGIC·ÖÐ͵ϼÕßÔÚPD-1¿¹ÌåÁªºÏ»¯ÁÆÖеÄÖÎÁÆ»ñÒæ£¨Ï£©
×ÛÉÏ£¬×÷ΪÊ׸öÃæÏò¡°PD-1¿¹Ìå+»¯ÁÆ¡±ÖÎÁÆÄ£Ê½ÏÂÍíÆÚʳ¹ÜÁÛ°©ÃâÒßÖÎÁƵĻùÒò×éÉúÎï±ê¼ÇÎï̽Ë÷£¬¸Ãת»¯Ñо¿Í¨¹ý¶ÔÃâÒßÔÐÔÖ¸±êµÄÓÅ»¯ºÍ¶ÔÄÍÒ©Ïà¹ØµÄÖÂÁö±äÒìÊÂÎñµÄϵͳÐÔÅжϼ°¶àά¶ÈÕûºÏ£¬¹¹½¨ÁË¿ÉÒÔ¾«×¼Ô¤²â»¯ÁÆÅä¾°ÏÂPD-1¿¹ÌåÖÎÁÆ»ñÒæµÄEGIC·ÖÐÍ£¬Ôö½øÁËÍíÆÚESCCÃâÒßÖÎÁƵĸöÌ廯¾öÒ顣ͬʱ£¬EGIC·ÖÐÍΪ½øÒ»²½Ì½Ë÷¸üÓÐÓõÄÍíÆÚESCCÃâÒß-°ÐÏòÁªºÏÖÎÁÆÕ½ÂÔÌṩÁËÐÂÆ«Ïò£¬¾ßÓпɹ۵Äת»¯Ô¶¾°¡£
¸ÃÑо¿»ñµÃÁ˹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð¡¢¡¢Öйúҽѧ¿ÆÑ§ÔºÒ½Ñ§¿ÆÑ§Ó뿵½¡¿Æ¼¼Á¢Ò칤³Ì¡¢¡¢¹ã¶«Ê¡¿Æ¼¼ÍýÏë¡¢¡¢¹ãÖÝÊпƼ¼ÍýÏëµÈÏîÄ¿µÄ×ÊÖú¡£ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÐìÈ𻪽ÌÊÚ¡¢¡¢Íõ·å½ÌÊÚΪ¸ÃÂÛÎĵÄÅäºÏͨѶ×÷Õߣ»£»³ÂÑÜÐв©Ê¿Ñо¿Éú¡¢¡¢Íõè÷Ï͸±Ö÷ÈÎҽʦ¡¢¡¢½ðÓ±¸±Ö÷ÈÎҽʦ¡¢¡¢ÕÔÆë¸±Ñо¿Ô±ÎªÅäºÏµÚÒ»×÷Õß¡£
ÂÛÎÄÁ´½Ó£º£º£ºhttps://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00089-2